Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

164.65
-4.1900-2.48%
Post-market: 164.650.00000.00%19:16 EDT
Volume:393.05K
Turnover:65.60M
Market Cap:9.85B
PE:-24.35
High:168.97
Open:168.01
Low:163.93
Close:168.84
Loading ...
OverviewCompanyAnalysisNewsFilings

Company Profile

Company Name:
Ascendis Pharma A/S
Exchange:
NASDAQ
Establishment Date:
2006
Employees:
1017
Office Location:
Tuborg Boulevard 12,Hellerup,Capital Region of Denmark,Denmark
Website:
http://www.ascendispharma.com
Zip Code:
2900
Phone:
45 70 22 22 44
Fax:
- -
Introduction:
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/? for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Directors

Name
Position
Jan Moller Mikkelsen
President, Chief Executive Officer, Board Member and Executive Director
Michael Wolff Jensen
Chairman and Senior Vice President, Chief Legal Officer
Albert Cha
Director
Birgitte Volck
Director
James I. Healy
Director
Lars Holtug
Director
Lisa Bright
Director

Shareholders

Name
Position
Jan Moller Mikkelsen
President, Chief Executive Officer, Board Member and Executive Director
Dana Pizzuti
Senior Vice President, Development Operations
Flemming Steen Jensen
Senior Vice President, Product Supply
Jens Sigurd Okkels
Senior Vice President, Product Development
Jesper Hoiland
Senior Vice President, Global Chief Commercial Officer
Juha Punnonen
Senior Vice President, Head of Oncology
Kennett Sprogoe
Senior Vice President, Head of Innovation and Research
Lotte Sonderbjerg
Senior Vice President, Chief Administrative Officer
Mark Bach
Senior Vice President, Clinical Development and Medical Affairs for Endocrine Medical Sciences
Michael Wolff Jensen
Chairman and Senior Vice President, Chief Legal Officer
Scott T. Smith
Senior Vice President, Chief Financial Officer
Vibeke Miller Breinholt
Senior Vice President, Nonclinical Development and Bioanalysis
Peter Rasmussen
Vice President, Finance and Principal Accounting Officer